Pharmacological targeting of bone marrow mesenchymal stromal/stem cells for the treatment of hematological disorders

被引：5
|
作者：
Sugino N. [1 ,2 ]
Ichinohe T. [3 ]
Takaori-Kondo A. [2 ]
Maekawa T. [1 ]
Miura Y. [1 ]
机构：
[1] Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto
[2] Department of Hematology/Oncology, Graduate School of Medicine, Kyoto University, Kyoto
[3] Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima
来源：
Inflammation and Regeneration | / 37卷 / 1期
基金：
日本学术振兴会;
关键词：
Cell therapy; Hematopoiesis; Immunomodulation; Mesenchymal stromal/stem cell; Pharmacological modification; Regeneration;
D O I：
10.1186/s41232-017-0038-5
中图分类号：
学科分类号：
摘要：
The therapeutic effects of mesenchymal stromal/stem cells (MSCs) are mainly based on three characteristics: immunomodulation, tissue regeneration, and hematopoietic support. Cell therapy using culture-expanded MSCs is effective in some intractable bone and hemato-immune disorders; however, its efficacy is limited. In this article, we review the previous efforts to improve the clinical outcomes of cell therapy using MSCs for such disorders. We describe pharmacological targeting of endogenous bone marrow-derived MSCs as a crucial quality-based intervention to establish more effective MSC-based therapies. © 2017 The Author(s).
引用
收藏
相关论文
共 50 条
  • [31] GENERATION OF GENOTYPED ARTIFICIAL OOCYTES FROM ENDOMETRIAL STROMAL CELLS AND BONE MARROW MESENCHYMAL STEM CELLS
    Tsai, Shelun
    Xie, Philip
    Cheung, Stephanie
    Rosenwaks, Zev
    Palermo, Gianpiero D.
    FERTILITY AND STERILITY, 2024, 122 (04) : E53 - E53
  • [32] Equine Bone Marrow and Adipose Tissue Mesenchymal Stem/Stromal Cells Putatively Derive from Perivascular Stem Cells
    Esteves, C. L.
    Sheldrake, T.
    Sawson, L.
    Menghini, T.
    Khan, N.
    Peault, B.
    Donadeu, F. X.
    TISSUE ENGINEERING PART A, 2015, 21 : S48 - S49
  • [33] BONE MORPHOGENETIC PROTEINS, BONE-MARROW STROMAL CELLS, AND MESENCHYMAL STEM-CELLS - OWEN,MAUREEN REVISITED
    REDDI, AH
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1995, (313) : 115 - 119
  • [34] Evidence of allogeneic stromal engraftment in bone marrow using canine mesenchymal stem cells.
    Sandmaier, BM
    Storb, R
    Kniley, J
    Hardy, W
    Black, M
    Moseley, A
    Deans, R
    BLOOD, 1998, 92 (10) : 116A - 117A
  • [35] Bone marrow-derived mesenchymal stem cells versus bone marrow nucleated cells in the treatment of chondral defects
    Zhang, Yi
    Wang, Fuyou
    Chen, Jiarong
    Ning, Zhigang
    Yang, Liu
    INTERNATIONAL ORTHOPAEDICS, 2012, 36 (05) : 1079 - 1086
  • [36] Transcriptomic portrait of human Mesenchymal Stromal/Stem cells isolated from bone marrow and placenta
    Beatriz Roson-Burgo
    Fermin Sanchez-Guijo
    Consuelo Del Cañizo
    Javier De Las Rivas
    BMC Genomics, 15
  • [37] Bone marrow-derived mesenchymal stem cells versus bone marrow nucleated cells in the treatment of chondral defects
    Yi Zhang
    Fuyou Wang
    Jiarong Chen
    Zhigang Ning
    Liu Yang
    International Orthopaedics, 2012, 36 : 1079 - 1086
  • [38] Transcriptomic portrait of human Mesenchymal Stromal/Stem cells isolated from bone marrow and placenta
    Roson-Burgo, Beatriz
    Sanchez-Guijo, Fermin
    Del Canizo, Consuelo
    De las Rivas, Javier
    BMC GENOMICS, 2014, 15
  • [39] Regionally Restricted Hox Function in Adult Bone Marrow Multipotent Mesenchymal Stem/Stromal Cells
    Rux, Danielle R.
    Song, Jane Y.
    Swinehart, Ilea T.
    Pineault, Kyriel M.
    Schlientz, Aleesa J.
    Trulik, Kelsey G.
    Goldstein, Steve A.
    Kozloff, Ken M.
    Lucas, Daniel
    Wellik, Deneen M.
    DEVELOPMENTAL CELL, 2016, 39 (06) : 653 - 666
  • [40] Human bone marrow mesenchymal stromal/stem cells: current clinical applications and potential for hematology
    Miura, Yasuo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (02) : 122 - 128
12345